Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity
- 3 August 1991
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 338 (8762), 277-280
- https://doi.org/10.1016/0140-6736(91)90418-o
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Lack of mother to infant transmision of the hepatitis C virus (HCV)Journal of Hepatology, 1990
- Randomized controlled trial of recombinant alpha-2a interferon in chronic NANB posttransfufion hepatitisJournal of Hepatology, 1990
- One Year of Therapy of nonA, nonB/C chronic hepatitis with recombinant α-2a interferon (r-IFN) or lymphoblastoid α interferon (λ-IFN)Journal of Hepatology, 1990
- Measles and rubella antibodies in patients with chronic liver diseaseJournal of Hepatology, 1990
- HCV testing in low-risk populationThe Lancet, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- CLASSIFYING CHRONIC HEPATITISThe Lancet, 1989
- HAZARDS OF INTERFERON THERAPY FOR HBV-SERONEGATIVE CHRONIC HEPATITISThe Lancet, 1989
- Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disordersJournal of Hepatology, 1986